News Home

MEI Pharma Inc (MEIP) Stock: What Does the Chart Say Thursday?

Thursday, April 15, 2021 01:15 PM | InvestorsObserver Analysts
MEI Pharma Inc (MEIP) Stock: What Does the Chart Say Thursday?

Overall market sentiment has been high on MEI Pharma Inc (MEIP) stock lately. MEIP receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
MEI Pharma Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on MEIP!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With MEIP Stock Today?

MEI Pharma Inc (MEIP) stock is down -3.19% while the S&P 500 has risen 0.94% as of 1:11 PM on Thursday, Apr 15. MEIP is lower by -$0.12 from the previous closing price of $3.60 on volume of 612,200 shares. Over the past year the S&P 500 is higher by 46.29% while MEIP has risen 39.60%. MEIP lost -$0.36 per share in the over the last 12 months.

To screen for more stocks like MEI Pharma Inc click here.

More About MEI Pharma Inc

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer. Geographically, all the business activities function through the region of the United States.

Click Here to get the full Stock Score Report on MEI Pharma Inc (MEIP) Stock.

You May Also Like